Patent: 9,849,193
✉ Email this page to a colleague
Summary for Patent: 9,849,193
Title: | Nanoparticles for drug delivery |
Abstract: | The invention provides nanoparticles, methods for making nanoparticles, and methods for using nanoparticles. An important attribute of a drug delivery system is its ability to allow for spatial and temporal regulated drug release, thereby minimizing side effects and improving therapeutic efficacy of conventional pharmaceuticals. Iron oxide nanoparticles (NPs), specifically Fe304 nanoparticles, possess many appropriate qualities that make them a viable choice for drug delivery. |
Inventor(s): | Knipp; Ralph J. (Louisville, KY), Nantz; Michael H. (Louisville, KY) |
Assignee: | University of Louisville Research Foundation, Inc. (Louisville, KY) |
Application Number: | 14/766,726 |
Patent Claims: | see list of patent claims |
Details for Patent 9,849,193
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Acrotech Biopharma Llc | ZEVALIN | ibritumomab tiuxetan | Injection | 125019 | 02/19/2002 | ⤷ Try a Trial | 2033-02-08 |
Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 08/19/2011 | ⤷ Try a Trial | 2033-02-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |